| Literature DB >> 29514171 |
Tomoaki Kanaya1, Teruo Noguchi1, Fumiyuki Otsuka1, Yasuhide Asaumi1, Yu Kataoka1, Yoshiaki Morita2, Hiroyuki Miura1, Kazuhiro Nakao1, Masashi Fujino1, Tomohiro Kawasaki3, Kunihiro Nishimura4, Teruo Inoue5, Jagat Narula6, Satoshi Yasuda1.
Abstract
Aims: Coronary high-intensity plaques (HIPs) with a high plaque-to-myocardial signal intensity ratio (PMR) on non-contrast T1-weighted imaging in patients with stable coronary artery disease (CAD) are associated with future coronary events. To characterize the morphological substrate of HIP, we performed a correlative optical coherence tomography (OCT) study. Methods and results: We examined 137 lesions in 105 patients with stable angina pectoris or silent myocardial ischaemia scheduled for percutaneous coronary intervention (PCI) using a 3 T magnetic resonance scanner. Pre-interventional OCT was performed for PCI target lesions. HIP was defined as PMR ≥ 1.4. Of the 137 lesions, 34% were HIP and 66% were non-HIP. The prevalence of lipid-rich plaque (96% vs. 70%, P < 0.001), macrophage accumulation (65% vs. 46%, P = 0.046), cholesterol crystals (46% vs. 22%, P = 0.006), and healed plaque rupture (multiple layers of different optical densities overlaying a large lipid accumulation, 72% vs. 18%, P < 0.001) was significantly higher in the HIP group than the non-HIP group; no significant differences were observed for the presence of thin cap fibroatheroma, intracoronary thrombus, and plaque rupture between the two groups. Multivariable stepwise logistic regression analysis showed that HIP was significantly associated with the presence of healed plaque rupture [odds ratio (OR) 9.32; 95% confidence interval (95% CI) 4.05-22.71; P < 0.001] and lipid-rich plaque (OR 4.38; 95% CI 1.08-29.77; P = 0.038). Conclusions: The significant association between HIP- and OCT-derived healed plaque rupture and large lipid core provides new insights into the characteristics of high-risk plaques, even in clinically stable CAD.Entities:
Mesh:
Substances:
Year: 2019 PMID: 29514171 PMCID: PMC6302262 DOI: 10.1093/ehjci/jey035
Source DB: PubMed Journal: Eur Heart J Cardiovasc Imaging ISSN: 2047-2404 Impact factor: 6.875
Figure 3Representative non-HIP lesions on T1-weighted imaging with corresponding optical coherence tomography. Representative non-HIPs (white arrows) in the middle of the right coronary artery (PMR, 0.85) (A) and proximal left anterior descending artery (PMR, 0.93) (E). Coronary artery angiography revealed significant coronary stenosis (B and F) (yellow arrows). Optical coherence tomography showed that the target lesion was predominately comprised of fibrous plaque without attenuation (C and D). A typical red thrombus was observed in a non-HIP area (G). A higher power image of the white square in (G) is shown in (H). HIPs, high-intensity plaques; PMR, plaque-to-myocardium signal intensity ratio.
Clinical characteristics and angiographic findings
| All patients | HIP | Non-HIP | ||
|---|---|---|---|---|
| ( | ( | ( | ||
| Age (years) | 67 ± 11 | 68 ± 10 | 65 ± 11 | 0.176 |
| Male | 88 (84) | 37 (84) | 51 (84) | 1.000 |
| Hypertension | 78 (74) | 37 (84) | 41 (67) | 0.070 |
| Dyslipidaemia | 91 (87) | 39 (89) | 52 (85) | 0.773 |
| Diabetes mellitus | 40 (38) | 16 (36) | 24 (39) | 0.840 |
| Current smoker | 15 (14) | 5 (11) | 10 (16) | 0.577 |
| BMI (kg/m2) | 24.4 ± 3.2 | 24.7 ± 3.4 | 24.2 ± 3.0 | 0.475 |
| TC (mg/dL) | 163 ± 34 | 163 ± 32 | 163 ± 36 | 0.899 |
| LDL (mg/dL) | 91 ± 31 | 89 ± 27 | 92 ± 33 | 0.961 |
| HDL (mg/dL) | 48 ± 12 | 48 ± 13 | 47 ± 12 | 0.773 |
| TG (mg/dL) | 138 ± 62 | 139 ± 60 | 137 ± 64 | 0.798 |
| HbA1c (%) | 6.2 ± 0.8 | 6.1 ± 0.8 | 6.2 ± 0.8 | 0.598 |
| PMR | NA | 1.77 (1.50, 2.20) | 0.91 (0.83, 0.98) | <0.001 |
| Medications | ||||
| Aspirin | 103 (98) | 43 (98) | 60 (98) | 1.000 |
| Beta-blocker | 61 (58) | 28 (64) | 33 (54) | 0.423 |
| ACEI/ARB | 63 (60) | 28 (64) | 35 (57) | 0.551 |
| CCB | 41 (39) | 20 (45) | 21 (34) | 0.312 |
| Statins | 101 (96) | 43 (98) | 58 (95) | 0.638 |
| Target vessel ( | 0.885 | |||
| LAD | 84 (61) | 27 (59) | 57 (63) | |
| LCX | 12 (9) | 4 (9) | 8 (9) | |
| RCA | 41 (30) | 15 (32) | 26 (28) |
BMI, body mass index; ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin II receptor blocker; CCB, calcium channel blocker; HbA1c, glycosylated haemoglobin; HDL, high-density lipoprotein; HIP, high-intensity plaque; LAD, left anterior descending artery; LCX, left circumflex artery; LDL, low-density lipoprotein; NA, not applicable; PMR, plaque-to-myocardial signal intensity ratio; RCA, right coronary artery; TC, total cholesterol; TG, triglycerides.
Optical coherence tomography analysis
| HIP | Non-HIP | ||
|---|---|---|---|
| (46 segments) | (91 segments) | ||
| Lipid-rich plaque | 44 (96%) | 64 (70%) | <0.001 |
| Lipid length, mm | 5.9 (4.7, 7.8) | 3.6 (2.6, 4.6) | <0.001 |
| Maximum lipid arc (°) | 188 (169, 209) | 139 (90, 173) | <0.001 |
| Average lipid arc (°) | 159 (133, 174) | 99 (80, 147) | <0.001 |
| Lipid index | 895 (716, 1212) | 336 (220, 635) | <0.001 |
| Minimum fibrous cap thickness (μm) | 180 (150, 210) | 190 (150, 220) | 0.180 |
| TCFA | 4 (9%) | 4 (4%) | 0.442 |
| Healed plaque rupture | 33 (72%) | 16 (18%) | <0.001 |
| Plaque rupture | 6 (13%) | 14 (15%) | 0.802 |
| Calcification | 14 (30%) | 36 (40%) | 0.350 |
| Thrombus | 5 (11%) | 7 (8%) | 0.537 |
| Red thrombus | 1 (20%) | 1 (14%) | |
| White thrombus | 4 (80%) | 6 (86%) | |
| Macrophage accumulation | 30 (65%) | 42 (46%) | 0.046 |
| Cholesterol crystal | 21 (46%) | 20 (22%) | 0.006 |
| Microchannel | 20 (43%) | 31 (34%) | 0.349 |
HIP, high-intensity plaque; TCFA, thin cap fibroatheroma.
Association between HIP and OCT-derived parameters based on univariable and multivariable logistic regression analysis
| Univariable analysis | Multivariable analysis: Model 1 | Multivariable analysis: Model 2 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| OR | 95% CI | OR | 95% CI | OR | 95% CI | ||||
| Lipid-rich plaque | 9.28 | 2.60–59.37 | <0.001 | 3.34 | 0.73–24.16 | 0.125 | 4.38 | 1.08–29.77 | 0.038 |
| Lipid length (mm) | 2.24 | 1.72–3.08 | <0.001 | ||||||
| Maximum lipid arc (°) | 1.03 | 1.02–1.04 | <0.001 | ||||||
| Average lipid arc (°) | 1.03 | 1.02–1.05 | <0.001 | ||||||
| Lipid index | 1.42 | 1.21–1.80 | <0.001 | ||||||
| Minimum fibrous cap thickness (μm) | 1.00 | 0.99–1.00 | 0.091 | 1.00 | 0.99–1.01 | 0.486 | |||
| TCFA | 2.07 | 0.47–9.15 | 0.324 | 5.69 | 0.71–47.33 | 0.101 | |||
| Healed plaque rupture | 11.74 | 5.21–28.11 | <0.001 | 11.30 | 4.55–33.15 | <0.001 | 9.32 | 4.05 –22.71 | <0.001 |
| Plaque rupture | 0.83 | 0.28–2.23 | 0.712 | 0.75 | 0.21–2.63 | 0.652 | |||
| Calcification | 0.67 | 0.31–1.41 | 0.291 | 1.13 | 0.41–3.05 | 0.808 | |||
| Thrombus | 0.88 | 0.23–3.34 | 0.855 | 1.96 | 0.40–9.69 | 0.404 | |||
| Macrophage accumulation | 2.18 | 1.06–4.63 | 0.034 | 1.62 | 0.64–4.21 | 0.309 | |||
| Cholesterol crystal | 2.98 | 1.40–6.46 | 0.005 | 1.67 | 0.63–4.43 | 0.304 | |||
| Microchannel | 1.48 | 0.72–3.08 | 0.283 | 1.29 | 0.52–3.21 | 0.576 | |||
CI, confidence interval; HIP, high-intensity plaque; OCT, optical coherence tomography; OR, odds ratio; TCFA, thin cap fibroatheroma.